target-prioritization

Multi-source drug-target due-diligence — turn a ranked gene list (e.g. scRNA-seq DE output) into a per-gene dossier across UniProt, OpenTargets, and PubMed, plus a local cross-lineage DE scan, then re-rank by a configurable composite score (cross-lineage convergence + druggability + disease genetics + tractability + novelty). Disease-agnostic: configurable focus disease and cell-context queries.